Skip to main content
. 2024 Jan 10;12(1):E78–E89. doi: 10.1055/a-2117-8197

Table 2 Effect of bougienage on clinical and endoscopic endpoints.

Endpoints Center 1* Center 2* P
*Center 1: University Hospital Frankfurt; Center 2: Sana Klinikum Offenbach.
Clinical endpoints
Time span until freedom of dysphagia was achieved (months), median (range) 155 (0–1792) 186 (0–4107) 0.35
No. of Savary dilations until freedom from dysphagia was achieved, median (range) 3 (1–41) 9 (1–57) <0.001
No. of therapy episodes containing Savary dilations until long-term freedom of dysphagia was achieved, median (range) 2 (1–16) 1 (1–9) 0.011
Time span to recurrence of dysphagia, median (range) 99 (1–1042) 95 (5–1003) 0.88
Endoscopic endpoints
Predilator size, median (range) 9 (5–15) 7 (5–12) <0.001
Maximum dilator, median (range) 16 (10–18) 14 (9–16) <0.001
Difference in dilation diameter, median (range) 8 (3–15) 7 (0–10) 0.30
Dilator size of 15 mm is achieved, n (%) 158 (81.4) 22 (50.0) <0.001
Time span until dilator size of 15 mm was achieved (days), median (range) 2 (0–1743) 73 (0–750) <0.001
No. of Savary dilations until dilator size of 15 mm was achieved, median (range) 2 (1–27) 8 (2–28) <0.001
Dilator size of 15 mm is not achieved, n (%) 36 (18.6) 22 (50.0)
Time span until maximal dilator size was achieved (days), median (range) 41 (0–706) 60 (0–648) 0.001
No. of Savary dilations until maximal dilation size was achieved, median (range) 2 (1–22) 4 (1–12) 0.03